Clin2
NCT06469528Possibly a fitNot yet recruiting

Escalating heart treatment based on plaque imaging

Coronary Artery Disease

Treatments studied

Part of Heart & circulation clinical trials.

This trial tests whether adding a special scan to look at the fatty plaque in your arteries can help your doctor decide if you need stronger heart medication to prevent future heart attacks or strokes. If you have moderate blockages and signs of inflammation, you may be able to join.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
50 people
Ages
18 years to 90 years
Study type
Interventional

Who can take part

  • You are between 18 and 90 years old.
  • You have evidence of high risk for heart problems, such as having had a heart attack, a stroke, diabetes, or a high risk score.
  • You have at least one moderate narrowing (30-80%) in a heart artery, as seen on an angiogram.
  • You have been taking a stable dose of a statin (cholesterol medicine) for more than 4 weeks.
  • You have signs of inflammation in your body, shown by a C-reactive protein (CRP) blood test result of 2 or higher.
  • You are not pregnant, not planning pregnancy, and not able to have children (for women).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06095765Recruiting· Phase 3
Colchicine for heart disease after stent placement

This trial tests if colchicine, a common anti-inflammatory medicine, can help prevent future heart problems in people who have coronary artery disease and recently had a stent placed. It's for adults with at least one extra risk factor like diabetes, smoking, or high blood pressure.

Aalst
NCT06489119Recruiting
Studying plaque types in coronary artery disease with advanced imaging

This trial uses advanced imaging (OCT) and single-cell analysis to study different types of plaque in people with coronary artery disease. It aims to understand how these plaque types differ at a cellular level, which could lead to better treatments.

Harbin, Heilongjiang
NCT05175274Not yet recruiting· Phase 3
Colchicine to prevent first heart problems in at-risk adults

This study tests whether taking a daily low dose of colchicine, a medicine used for inflammation, can help prevent a first heart attack or other heart problems in people who are at higher risk due to their risk factors. If you qualify, you would be assigned to take either colchicine or a placebo (a pill with no active medicine) to see if it helps keep your heart healthy.

Qingdao, Shandong
NCT07286578Recruiting
Using heart CT scans to guide treatment for blocked arteries

This trial is testing whether a special heart CT scan (coronary CT angiography) can help doctors better understand and treat calcium buildup in your heart arteries. If you have a type of heart disease that might need a stent or other procedure, this study could help decide the best approach.

Boston, Massachusetts
NCT07349875Recruiting· Phase 4
Colchicine for non-severe coronary plaque: a trial

This trial tests if the anti-inflammatory drug colchicine can help people with non-severe coronary artery plaque seen on a CT scan. It may be an option if you have stable chest pain or related symptoms and your heart arteries are partly blocked but not severely.

Nanjing
NCT07232069Recruiting· Phase 3
Early heart disease trial for women and men with mild plaque buildup

This trial tests whether two medicines, a statin and colchicine, can slow or stop early heart artery plaque from growing in people who have mild plaque but no heart disease symptoms yet. It uses special CT scans to measure plaque over 2 years.

Birmingham, Alabama

Hear when a new Coronary artery disease trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.